Reports - Molecular Diagnostics Market
HealthcareMolecular Diagnostics Market
Molecular Diagnostics Market Valuation and Future Projections to 2035 by Product & Service (Reagents & Kits, Instruments, Services & Software) by Test Type (Lab Tests, PoC Tests) by Sample Type (Blood, Serum, & Plasma, Urine, Other Sample Types) by Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, In Situ Hybridization, DNA Microarrays, Other Technologies) by Application (Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, COVID-19, Other Applications) by End User (Diagnostic Laboratories, Hospitals & Clinics, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Molecular Diagnostics Market - Segment Analysis
1. Overview
2. Global Molecular Diagnostics Market, 2021 - 2035 (USD Million)
3. Global Molecular Diagnostics Market - by Product & Service
3.1. By Reagents & Kits
3.2. By Instruments
3.3. By Services & Software
4. Global Molecular Diagnostics Market - by Test Type
4.1. By Lab Tests
4.2. By PoC Tests
5. Global Molecular Diagnostics Market - by Sample Type
5.1. By Blood, Serum, & Plasma
5.2. By Urine
5.3. By Other Sample Types
6. Global Molecular Diagnostics Market - by Technology
6.1. By Polymerase Chain Reaction
6.2. By Isothermal Nucleic Acid Amplification Technology
6.3. By DNA Sequencing & Next-generation Sequencing
6.4. By In Situ Hybridization
6.5. By DNA Microarrays
6.6. By Other Technologies
7. Global Molecular Diagnostics Market - by Application
7.1. By Infectious Disease Diagnostics
7.2. By Oncology Testing
7.3. By Genetic Testing
7.4. By COVID-19
7.5. By Other Applications
8. Global Molecular Diagnostics Market - by End User
8.1. By Diagnostic Laboratories
8.2. By Hospitals & Clinics
8.3. By Other End Users
9. Global Molecular Diagnostics Market - by region
9.1. North America
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
10. Market comparative analysis
Chapter 4 North America Molecular Diagnostics Market - Segment Analysis
1. Overview
2. North America Molecular Diagnostics Market, 2021 - 2035 (USD Million)
3. North America Molecular Diagnostics Market - by Product & Service
3.1. By Reagents & Kits
3.2. By Instruments
3.3. By Services & Software
4. North America Molecular Diagnostics Market - by Test Type
4.1. By Lab Tests
4.2. By PoC Tests
5. North America Molecular Diagnostics Market - by Sample Type
5.1. By Blood, Serum, & Plasma
5.2. By Urine
5.3. By Other Sample Types
6. North America Molecular Diagnostics Market - by Technology
6.1. By Polymerase Chain Reaction
6.2. By Isothermal Nucleic Acid Amplification Technology
6.3. By DNA Sequencing & Next-generation Sequencing
6.4. By In Situ Hybridization
6.5. By DNA Microarrays
6.6. By Other Technologies
7. North America Molecular Diagnostics Market - by Application
7.1. By Infectious Disease Diagnostics
7.2. By Oncology Testing
7.3. By Genetic Testing
7.4. By COVID-19
7.5. By Other Applications
8. North America Molecular Diagnostics Market - by End User
8.1. By Diagnostic Laboratories
8.2. By Hospitals & Clinics
8.3. By Other End Users
Chapter 5 Europe Molecular Diagnostics Market - Segment Analysis
1. Overview
2. Europe Molecular Diagnostics Market, 2021 - 2035 (USD Million)
3. Europe Molecular Diagnostics Market - by Product & Service
3.1. By Reagents & Kits
3.2. By Instruments
3.3. By Services & Software
4. Europe Molecular Diagnostics Market - by Test Type
4.1. By Lab Tests
4.2. By PoC Tests
5. Europe Molecular Diagnostics Market - by Sample Type
5.1. By Blood, Serum, & Plasma
5.2. By Urine
5.3. By Other Sample Types
6. Europe Molecular Diagnostics Market - by Technology
6.1. By Polymerase Chain Reaction
6.2. By Isothermal Nucleic Acid Amplification Technology
6.3. By DNA Sequencing & Next-generation Sequencing
6.4. By In Situ Hybridization
6.5. By DNA Microarrays
6.6. By Other Technologies
7. Europe Molecular Diagnostics Market - by Application
7.1. By Infectious Disease Diagnostics
7.2. By Oncology Testing
7.3. By Genetic Testing
7.4. By COVID-19
7.5. By Other Applications
8. Europe Molecular Diagnostics Market - by End User
8.1. By Diagnostic Laboratories
8.2. By Hospitals & Clinics
8.3. By Other End Users
Chapter 6 Asia Pacific Molecular Diagnostics Market - Segment Analysis
1. Overview
2. Asia Pacific Molecular Diagnostics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Molecular Diagnostics Market - by Product & Service
3.1. By Reagents & Kits
3.2. By Instruments
3.3. By Services & Software
4. Asia Pacific Molecular Diagnostics Market - by Test Type
4.1. By Lab Tests
4.2. By PoC Tests
5. Asia Pacific Molecular Diagnostics Market - by Sample Type
5.1. By Blood, Serum, & Plasma
5.2. By Urine
5.3. By Other Sample Types
6. Asia Pacific Molecular Diagnostics Market - by Technology
6.1. By Polymerase Chain Reaction
6.2. By Isothermal Nucleic Acid Amplification Technology
6.3. By DNA Sequencing & Next-generation Sequencing
6.4. By In Situ Hybridization
6.5. By DNA Microarrays
6.6. By Other Technologies
7. Asia Pacific Molecular Diagnostics Market - by Application
7.1. By Infectious Disease Diagnostics
7.2. By Oncology Testing
7.3. By Genetic Testing
7.4. By COVID-19
7.5. By Other Applications
8. Asia Pacific Molecular Diagnostics Market - by End User
8.1. By Diagnostic Laboratories
8.2. By Hospitals & Clinics
8.3. By Other End Users
Chapter 7 Latin America Molecular Diagnostics Market - Segment Analysis
1. Overview
2. Latin America Molecular Diagnostics Market, 2021 - 2035 (USD Million)
3. Latin America Molecular Diagnostics Market - by Product & Service
3.1. By Reagents & Kits
3.2. By Instruments
3.3. By Services & Software
4. Latin America Molecular Diagnostics Market - by Test Type
4.1. By Lab Tests
4.2. By PoC Tests
5. Latin America Molecular Diagnostics Market - by Sample Type
5.1. By Blood, Serum, & Plasma
5.2. By Urine
5.3. By Other Sample Types
6. Latin America Molecular Diagnostics Market - by Technology
6.1. By Polymerase Chain Reaction
6.2. By Isothermal Nucleic Acid Amplification Technology
6.3. By DNA Sequencing & Next-generation Sequencing
6.4. By In Situ Hybridization
6.5. By DNA Microarrays
6.6. By Other Technologies
7. Latin America Molecular Diagnostics Market - by Application
7.1. By Infectious Disease Diagnostics
7.2. By Oncology Testing
7.3. By Genetic Testing
7.4. By COVID-19
7.5. By Other Applications
8. Latin America Molecular Diagnostics Market - by End User
8.1. By Diagnostic Laboratories
8.2. By Hospitals & Clinics
8.3. By Other End Users
Chapter 8 Middle East & Africa Molecular Diagnostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Molecular Diagnostics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Molecular Diagnostics Market - by Product & Service
3.1. By Reagents & Kits
3.2. By Instruments
3.3. By Services & Software
4. Middle East & Africa Molecular Diagnostics Market - by Test Type
4.1. By Lab Tests
4.2. By PoC Tests
5. Middle East & Africa Molecular Diagnostics Market - by Sample Type
5.1. By Blood, Serum, & Plasma
5.2. By Urine
5.3. By Other Sample Types
6. Middle East & Africa Molecular Diagnostics Market - by Technology
6.1. By Polymerase Chain Reaction
6.2. By Isothermal Nucleic Acid Amplification Technology
6.3. By DNA Sequencing & Next-generation Sequencing
6.4. By In Situ Hybridization
6.5. By DNA Microarrays
6.6. By Other Technologies
7. Middle East & Africa Molecular Diagnostics Market - by Application
7.1. By Infectious Disease Diagnostics
7.2. By Oncology Testing
7.3. By Genetic Testing
7.4. By COVID-19
7.5. By Other Applications
8. Middle East & Africa Molecular Diagnostics Market - by End User
8.1. By Diagnostic Laboratories
8.2. By Hospitals & Clinics
8.3. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Becton Dickinson and Company (U.S.)
2. bioMérieux SA (France)
3. Bio-Rad Laboratories Inc. (U.S.)
4. Abbott Laboratories (U.S.)
5. Agilent Technologies Inc. (U.S.)
6. Danaher Corp. (U.S.)
7. Hologic Inc. (U.S.)
8. Illumina Inc. (U.S.)
9. Johnson & Johnson Services Inc. (U.S.)
10. Grifols S.A. (Spain)
11. QIAGEN (Germany)
12. F. Hoffmann-La Roche Ltd. (Switzerland)
13. Siemens Healthineers AG (Germany)
14. Sysmex Corporation (Japan)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By